OBJECTIVES: To evaluate early (<100 d) treatment-related mortality (TRM) in autologous stem cell transplant (ASCT) recipients. PATIENTS: Altogether 1482 adult patients received ASCT in six Finnish centres 1990-2003. The most common diagnoses were non-Hodgkin's lymphoma (NHL) (n = 542), multiple myeloma (MM) (n = 528), breast cancer (BC) (n = 132), Hodgkin's lymphoma (n = 86) and chronic lymphocytic leukaemia (CLL) (n = 63). RESULTS: Forty-two patients (2.8%) died from treatment-related reasons <100 d from ASCT. The median time to death was 38 d from ASCT (0-99). The risk of TRM varied according to the diagnoses. The highest risk was observed in patients with AL amyloidosis (24%) followed by NHL (4.4%) and MM (1.9%). No early TRM was observed in patients transplanted for BC or CLL. Infections were the cause of death in 16 patients (fungal 7, bacterial 6, viral 3). Organ toxicity was responsible for early death in 26 patients (heart 9, lungs 7, other 10). CONCLUSIONS: This nation-wide survey indicated a low early TRM in ASCT recipients in general, but higher risks in patients with AL amyloidosis or NHL. In addition to patient selection, also optimization of transplant procedure may be needed in these patient groups to reduce early TRM.
OBJECTIVES: To evaluate early (<100 d) treatment-related mortality (TRM) in autologous stem cell transplant (ASCT) recipients. PATIENTS: Altogether 1482 adult patients received ASCT in six Finnish centres 1990-2003. The most common diagnoses were non-Hodgkin's lymphoma (NHL) (n = 542), multiple myeloma (MM) (n = 528), breast cancer (BC) (n = 132), Hodgkin's lymphoma (n = 86) and chronic lymphocytic leukaemia (CLL) (n = 63). RESULTS: Forty-two patients (2.8%) died from treatment-related reasons <100 d from ASCT. The median time to death was 38 d from ASCT (0-99). The risk of TRM varied according to the diagnoses. The highest risk was observed in patients with AL amyloidosis (24%) followed by NHL (4.4%) and MM (1.9%). No early TRM was observed in patients transplanted for BC or CLL. Infections were the cause of death in 16 patients (fungal 7, bacterial 6, viral 3). Organ toxicity was responsible for early death in 26 patients (heart 9, lungs 7, other 10). CONCLUSIONS: This nation-wide survey indicated a low early TRM in ASCT recipients in general, but higher risks in patients with AL amyloidosis or NHL. In addition to patient selection, also optimization of transplant procedure may be needed in these patient groups to reduce early TRM.
Authors: Chafic Karam; Christopher J Klein; Angela Dispenzieri; P James B Dyck; Jay Mandrekar; Anita D'Souza; Michelle L Mauermann Journal: Neurology Date: 2015-04-15 Impact factor: 9.910
Authors: Stevan E Hobfoll; James I Gerhart; Alyson K Zalta; Kurrie Wells; John Maciejewski; Henry Fung Journal: Psychooncology Date: 2015-01-27 Impact factor: 3.894
Authors: Derliz Mereles; Sebastian J Buss; Stefan E Hardt; Werner Hunstein; Hugo A Katus Journal: Clin Res Cardiol Date: 2010-03-10 Impact factor: 5.460
Authors: Noemí Puig; Javier de la Rubia; Isidro Jarque; Miguel Salavert; Pau Montesinos; Jaime Sanz; Guillermo Martín; Guillermo Sanz; Susana Cantero; Ignacio Lorenzo; Miguel A Sanz Journal: Int J Hematol Date: 2007-08 Impact factor: 2.490
Authors: Raymond Q Migrino; Ravi K Mareedu; Daniel Eastwood; Mark Bowers; Leanne Harmann; Parameswaran Hari Journal: J Am Soc Echocardiogr Date: 2009-10-31 Impact factor: 5.251
Authors: M Koenigsmann; J Casper; C Kahl; N Basara; H G Sayer; G Behre; S Theurich; M Christopeit; M Mohren; A Reichle; B Metzner; A Ganser; M Stadler; L Uharek; L Balleisen; A Hinke; R Hinke; D Niederwieser Journal: Bone Marrow Transplant Date: 2013-12-23 Impact factor: 5.483
Authors: Niloufer Khan; Sarah Lindner; Antonio L C Gomes; Sean M Devlin; Gunjan L Shah; Anthony D Sung; Craig S Sauter; Heather J Landau; Parastoo B Dahi; Miguel-Angel Perales; David J Chung; Alexander M Lesokhin; Anqi Dai; Annelie Clurman; John B Slingerland; Ann E Slingerland; Daniel G Brereton; Paul A Giardina; Molly Maloy; Gabriel K Armijo; Carlos Rondon-Clavo; Emily Fontana; Lauren Bohannon; Sendhilnathan Ramalingam; Amy T Bush; Meagan V Lew; Julia A Messina; Eric Littmann; Ying Taur; Robert R Jenq; Nelson J Chao; Sergio Giralt; Kate A Markey; Eric G Pamer; Marcel R M van den Brink; Jonathan U Peled Journal: Blood Date: 2021-03-18 Impact factor: 25.476